A detailed history of Intrust Bank Na transactions in Biogen Inc. stock. As of the latest transaction made, Intrust Bank Na holds 1,167 shares of BIIB stock, worth $175,796. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,167
Previous 1,591 26.65%
Holding current value
$175,796
Previous $368,000 38.59%
% of portfolio
0.02%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$189.07 - $236.8 $80,165 - $100,403
-424 Reduced 26.65%
1,167 $226,000
Q2 2024

Aug 08, 2024

SELL
$190.52 - $236.72 $25,720 - $31,957
-135 Reduced 7.82%
1,591 $368,000
Q1 2024

May 09, 2024

SELL
$212.02 - $267.71 $49,188 - $62,108
-232 Reduced 11.85%
1,726 $372,000
Q4 2023

Feb 05, 2024

BUY
$222.59 - $267.94 $26,933 - $32,420
121 Added 6.59%
1,958 $506,000
Q3 2023

Nov 13, 2023

SELL
$253.3 - $285.89 $25,330 - $28,589
-100 Reduced 5.16%
1,837 $472,000
Q2 2023

Aug 10, 2023

SELL
$275.25 - $318.06 $28,901 - $33,396
-105 Reduced 5.14%
1,937 $551,000
Q1 2023

May 04, 2023

BUY
$256.56 - $292.34 $133,924 - $152,601
522 Added 34.34%
2,042 $567,000
Q4 2022

Feb 10, 2023

BUY
$252.44 - $306.72 $60,333 - $73,306
239 Added 18.66%
1,520 $420,000
Q3 2022

Nov 09, 2022

BUY
$194.69 - $268.46 $15,769 - $21,745
81 Added 6.75%
1,281 $342,000
Q2 2022

Aug 16, 2022

BUY
$187.54 - $223.02 $6,001 - $7,136
32 Added 2.74%
1,200 $244,000
Q1 2022

May 10, 2022

BUY
$193.77 - $244.14 $36,428 - $45,898
188 Added 19.18%
1,168 $246,000
Q4 2021

Feb 03, 2022

SELL
$223.92 - $287.77 $87,552 - $112,518
-391 Reduced 28.52%
980 $235,000
Q3 2021

Nov 04, 2021

BUY
$282.99 - $369.05 $3,395 - $4,428
12 Added 0.88%
1,371 $388,000
Q2 2021

Aug 05, 2021

SELL
$259.0 - $414.71 $31,598 - $50,594
-122 Reduced 8.24%
1,359 $470,000
Q1 2021

Jun 02, 2021

SELL
$242.95 - $284.63 $107,140 - $125,521
-441 Reduced 22.94%
1,481 $414,000
Q4 2020

Feb 10, 2021

SELL
$236.26 - $355.63 $67,334 - $101,354
-285 Reduced 12.91%
1,922 $470,000
Q3 2020

Nov 05, 2020

SELL
$264.77 - $305.71 $98,229 - $113,418
-371 Reduced 14.39%
2,207 $627,000
Q2 2020

Aug 05, 2020

SELL
$258.66 - $342.55 $30,521 - $40,420
-118 Reduced 4.38%
2,578 $689,000
Q1 2020

May 06, 2020

BUY
$268.85 - $341.04 $199,486 - $253,051
742 Added 37.97%
2,696 $853,000
Q4 2019

Feb 07, 2020

BUY
$220.06 - $304.07 $22,666 - $31,319
103 Added 5.56%
1,954 $580,000
Q3 2019

Nov 12, 2019

SELL
$217.44 - $243.88 $1,956 - $2,194
-9 Reduced 0.48%
1,851 $431,000
Q2 2019

Aug 12, 2019

SELL
$219.29 - $241.72 $95,171 - $104,906
-434 Reduced 18.92%
1,860 $435,000
Q1 2019

May 10, 2019

SELL
$216.71 - $338.96 $32,289 - $50,505
-149 Reduced 6.1%
2,294 $542,000
Q4 2018

Feb 06, 2019

BUY
$278.5 - $352.75 $26,179 - $33,158
94 Added 4.0%
2,443 $735,000
Q3 2018

Nov 09, 2018

BUY
$293.51 - $383.83 $45,200 - $59,109
154 Added 7.02%
2,349 $830,000
Q2 2018

Aug 08, 2018

SELL
$257.52 - $306.91 $53,049 - $63,223
-206 Reduced 8.58%
2,195 $637,000
Q1 2018

May 03, 2018

SELL
$260.13 - $367.91 $10,665 - $15,084
-41 Reduced 1.68%
2,401 $657,000
Q4 2017

Feb 08, 2018

BUY
$307.64 - $344.58 $39,685 - $44,450
129 Added 5.58%
2,442 $778,000
Q3 2017

Nov 06, 2017

BUY
$281.15 - $329.69 $650,299 - $762,572
2,313
2,313 $724,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Intrust Bank Na Portfolio

Follow Intrust Bank Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.